# Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder

> **NCT01260311** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 508 (actual)

## Conditions studied

- Over Active Bladder

## Interventions

- **DRUG:** Fesoterodine

## Key facts

- **NCT ID:** NCT01260311
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 508 (ACTUAL)
- **Last updated:** 2014-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01260311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01260311, "Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01260311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*